This handout is for infective endocarditis (duke-iscvid). Your care team identified this based on: fever + new murmur / vegetation (acc/aha 2022).
Other reasons your team may use this plan: persistent bacteremia (≥2 sets, typical organism) (acc/aha 2022); embolic stroke, septic emboli, janeway / osler / roth (acc/aha 2022); tte/tee vegetation, abscess, prosthetic dehiscence (acc/aha 2022).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| vancomycin | 25–30 mg/kg load IV → 15–20 mg/kg q8–12h targeting AUC24 400–600 | IV | q8–12h | Covers MRSA + Streptococci; AUC-guided dosing (ACC/AHA 2022) |
| ceftriaxone | 2 g IV q24h | IV | q24h | Covers Streptococci, HACEK (ACC/AHA 2022) |
| ampicillin | 2 g IV q4h | IV | q4h | Covers Enterococci (ACC/AHA 2022) |
| gentamicin | 3 mg/kg/d IV (divided q8h or once daily) — synergy | IV | q8h | AHA 2015 — no longer routine for native S. aureus IE |
Plan: IE pathogen-directed antibiotics + surgical decision (2023 AHA/ACC + ESC)
Call 911 or go to the nearest emergency room right away if you have:
Post-treatment echo; dental clearance; long-term IE prophylaxis per AHA/ESC indications
Guideline: 2023 AHA/ACC IE focused update + ESC 2023 IE Guidelines + Duke-ISCVID 2023 + POET (NEJM 2019)